Samsung Biologics Co., Ltd. (207940)
Market Closed
15 Oct, 06:30 AM
KRX SM KRX SM Primary ₩
1,247,000. 00
+65,000
+5.4992%
₩
76.33T Market Cap
- P/E Ratio
- Div Yield
139,442 Volume
13,763 Eps
₩ 1,182,000
Previous Close Want to track 207940 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Samsung Biologics Co., Ltd. (207940) Statistics
Valuation metrics
Market Cap 76.33T
Enterprise value 57.38T
Trailing P/E (ttm) 28.42
Forward P/E -
PEG ratio 0.52
Price/Sales (ttm) 12.41
Price/Book (mrq) 6.75
Enterprise Value/Revenue 12.62
Enterprise Value/EBITDA 19.42
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 62.36K
Average volume (90 days) 48.44K
Price summary
52-Week low 1,150,000
52-Week high 1,987,000
Beta -
50-Day moving average 1,437,656.25
200-Day moving average 1,451,354.48
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 0.65:1
Last split Date 30 Oct 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.44%
Operating margin 0.44%
Operational effectiveness
Return on assets 0.16%
Return on equity 0.22%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 98,222.39
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 42,867.03
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 47,278.64
Total debt (mrq) -
Total Debt/Equity (mrq) 0.15
Current ratio (mrq) 1.8%
Book value per share (mrq) 180,638.21
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
